PPM1D is considered to be a proto-oncogene due to its role in negative regulation of p53 and its overexpression in breast, gastric, and pancreatic cancers, as well as in other tumors (reviewed [15]). This evidence concerns the gene TP53 and pancreatic neoplasm.